Peter Parten
Orthopaedic Surgery · Vadnais Heights, MNNPI 1881663805
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 94.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $19,471 and has fallen 87.8% since, to $2,382 in 2025.
Across 99 payments — averaging $269.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$25K
- Stryker$526
- Foundation Medical, LLC$396
- Gemini Medical LLC$289
- Shoulder Innovations, Inc.$181
- Gemini Mountain Medical, LLC$32
- plus $15 from 1 others
What the payments were for
- Speaking & faculty fees$16,00060%
- Travel & lodging$7,97130%
- Food & beverage$2,74410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 78 | $25,275 |
| Stryker | 9 | $526 |
| Foundation Medical, LLC | 5 | $396 |
| Gemini Medical LLC | 3 | $289 |
| Shoulder Innovations, Inc. | 2 | $181 |
| Gemini Mountain Medical, LLC | 1 | $32 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PANGEA$173
- T2$170
- InSet System$131
How this compares
$26,715 in reported general payments places this provider in the 80th percentile of 533 orthopaedic surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 13 | $330 |
| Amoxicillin | 19 | $22 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Vadnais Heights
- Daniel BerryRochester$21.5M
- Mark PagnanoRochester$14.8M
- Robert TrousdaleRochester$12.2M
- John SperlingRochester$12.2M
- Shawn O'DriscollRochester$10.5M
- Bryan Den HartogStillwater$9M
- Joseph NesslerSartell$8.6M
- David LewallenRochester$8M
- Rafael SierraRochester$4.9M
- Mark DahlOak Park Heights$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.